Riskpilot← Back to searchSign inGet full accessCAERUS CONSULTING AS
ASActiveOrg 994038567Kalvenveien 89, 4916 BorøyResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20091 employeeswww.c10pharma.com
Revenue 2024
NOK 4,3M
-15% vs 2023
EBITDA margin
66.4%
-24% vs 2023
Equity ratio
91.5%
Financial strength
Net profit 2024
NOK 2,4M
-36% vs 2023
| Revenue | NOK 4,3M | -15% |
| EBITDA | NOK 2,9M | -24% |
| Net profit | NOK 2,4M | -36% |
| Total assets | NOK 10,7M | +34% |
| Equity | NOK 9,8M | +26% |
| Employees | 1 | — |
Legal name
CAERUS CONSULTING AS
Org number
994038567
Legal form
Aksjeselskap
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
9. mai 2009
Share capital
NOK 47 523
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Produktutvikling i farmasøytisk industri, konsulentvirksomhet samt deltakelse i andre foretak.
Address
Kalvenveien 89, 4916 Borøy
Website
www.c10pharma.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 812 | 2 180 | 4 748 | 2 841 | 1 226 | 505 | 221 | 2 211 | 3 249 | 2 861 | 4 138 | 4 821 | 5 461 | 5 422 | 5 097 | 4 317 |
| Staff expenses | −144 | −1 079 | −1 249 | −1 051 | −593 | −581 | −0 | −1 | −392 | −258 | −440 | −688 | −738 | −864 | −950 | −1 053 |
| EBITDA | 133 | −1 722 | −3 916 | −4 789 | −5 144 | −2 274 | −63 | 2 073 | 2 705 | 2 535 | 3 219 | 3 794 | 4 514 | 3 914 | 3 758 | 2 865 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | 133 | −1 722 | −3 916 | −4 789 | −5 144 | −2 274 | −63 | 2 073 | 2 705 | 2 535 | 3 219 | 3 794 | 4 514 | 3 914 | 3 758 | 2 865 |
| Net financials | 0 | 18 | 62 | −447 | −1 095 | −747 | −498 | 17 | 29 | 16 | 64 | −266 | 519 | 340 | 61 | 237 |
| Profit before tax | 133 | −1 705 | −3 853 | −5 236 | −6 239 | −3 021 | −561 | 2 090 | 2 734 | 2 552 | 3 283 | 3 528 | 5 033 | 4 254 | 3 819 | 3 102 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | 29 | 668 |
| Net profit | 133 | −1 705 | −3 853 | −5 236 | −6 239 | −3 021 | −561 | 2 090 | 2 734 | 2 552 | 3 283 | 3 528 | 5 033 | 4 254 | 3 789 | 2 434 |
| Item | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 698 | 5 401 | 4 144 | 4 243 | 5 691 | 1 499 | 408 | 2 207 | 3 184 | 4 571 | 3 857 | 6 444 | 5 344 | 6 206 | 7 961 | 10 664 |
| Equity | 235 | 4 059 | 2 966 | −2 270 | −2 634 | −5 655 | 384 | 2 155 | 2 862 | 2 899 | 3 669 | 5 583 | 5 176 | 4 930 | 7 719 | 9 754 |
| Long-term debt | 0 | 0 | 0 | 5 000 | 6 600 | 7 112 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 463 | 1 341 | 1 178 | 1 513 | 1 725 | 43 | 24 | 53 | 323 | 1 672 | 188 | 861 | 168 | 1 276 | 242 | 910 |
| Total debt | 463 | 1 341 | 1 178 | 6 513 | 8 325 | 7 155 | 24 | 53 | 323 | 1 672 | 188 | 861 | 168 | 1 276 | 242 | 910 |
EBITDA margin
66.4%
This company
15.8%
Market median
+320% vs market
20092024
Equity ratio
91.5%
This company
38.2%
Market median
+140% vs market
20092024
Return on equity
25.0%
This company
18.4%
Market median
+36% vs market
20092024
Net profit margin
56.4%
This company
8.1%
Market median
+596% vs market
20092024
Asset turnover
0.40×
This company
1.12×
Market median
-64% vs market
20092024
Debt / equity
0.09×
This company
0.62×
Market median
+85% vs market
20092024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
- Annual report 2011Filed via Brønnøysundsregistrene · Period 2011-01-01 – 2011-12-31
- Annual report 2010Filed via Brønnøysundsregistrene · Period 2010-01-01 – 2010-12-31
- Annual report 2009Filed via Brønnøysundsregistrene · Period 2009-03-31 – 2009-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2024 | — | — | |
| Chairman | 2015 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of CAERUS CONSULTING AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sissel Annie Nuth Davidsson | Board of Directors | 0 companies |
| Torgeir Vaage | Chairman | 0 companies |